| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/18/2011 | CN102058540A Azithromycin sustained-release microsphere and dry suspension, preparation method and application thereof |
| 05/18/2011 | CN102058520A Cream for promoting tissue regeneration and restraining sores and preparation method thereof |
| 05/18/2011 | CN102058512A Topical skin care formulations |
| 05/18/2011 | CN102058507A Health toothpaste prepared from multiple valuable Chinese medicinal materials for preventing and treating oral diseases |
| 05/18/2011 | CN101780121B Product capable of improving skin metabolism and deferring senility and preparation method thereof |
| 05/18/2011 | CN101697994B Radiation-resistant and fatigue-resistant agent and preparation method thereof |
| 05/18/2011 | CN101693040B Medicament for treating onychomycosis and preparation method thereof |
| 05/18/2011 | CN101690783B External medicine for curing onychomycosis |
| 05/18/2011 | CN101601693B Externally used medicine for curing acne |
| 05/18/2011 | CN101450141B Medicine for treating alopecia |
| 05/18/2011 | CN101407536B Process for preparing high-purity asiaticoside by solvent crystallization |
| 05/18/2011 | CN101406652B Chinese medicine capsule for treating tinea corporis |
| 05/18/2011 | CN101390830B Anarexol cream and preparation method thereof |
| 05/18/2011 | CN101385745B Agent which is anti-adhesive in relation to the pathogenic flora of the skin |
| 05/18/2011 | CN101288678B Production method of pearl powder |
| 05/18/2011 | CN101242829B Pharmaceutical composition comprising PPAR regulator |
| 05/17/2011 | US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943583 2-O-(β-D-glucopyranosyl) ascorbic acid, process for its production, and foods cosmetics containing compositions comprising it |
| 05/17/2011 | US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | US7943157 copolymer based on acryloxydimethyltaurine; water soluble, water swelling |
| 05/17/2011 | US7943152 By injection into the eyelid or conjunctiva to reduce secretions from the meibomian glands; nonsurgical; antisecretory agents |
| 05/17/2011 | CA2498944C Amino alcohol derivatives, salts thereof and immunosuppressive agents |
| 05/17/2011 | CA2493496C Antiaging composition |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2411409C Vitamin d derivatives |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/12/2011 | WO2011057269A2 Compositions for enhancing hair growth |
| 05/12/2011 | WO2011057129A2 Compositions and methods for stimulating hair growth |
| 05/12/2011 | WO2011056667A2 Rosacea topical skin treatment method and formulation |
| 05/12/2011 | WO2011056502A1 Bone morphogenetic protein receptor type ii compositions and methods of use |
| 05/12/2011 | WO2011056497A1 Activin receptor type iib compositions and methods of use |
| 05/12/2011 | WO2011056382A1 Angiogenesis promoted by caged growth factors |
| 05/12/2011 | WO2011056116A1 Composition for promoting wound healing |
| 05/12/2011 | WO2011056017A2 Mass propagation method for hair follicle stem cells |
| 05/12/2011 | WO2011055838A1 Compound for inhibiting biosynthesis of testosterone |
| 05/12/2011 | WO2011055561A1 Protein crosslinking inhibitor and use thereof |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011055270A1 Indole based receptor crth2 antagonists |
| 05/12/2011 | WO2011055034A1 Use of yeast peptide hydrolysate as an active agent for strengthening hair |
| 05/12/2011 | WO2011055033A2 Use of a corn peptide hydrolysate as an active agent stimulating hair growth |
| 05/12/2011 | WO2011054805A1 Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions |
| 05/12/2011 | WO2011054301A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | WO2011054090A1 Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith |
| 05/12/2011 | WO2011013909A9 Composition containing oligo-hyaluronic acid for promoting the stemness of skin cells and for stimulating differentiation |
| 05/12/2011 | WO2011005749A3 Topical antifungal composition |
| 05/12/2011 | WO2011003062A3 Probiotic compositions and processes thereof |
| 05/12/2011 | WO2010149384A3 Hybrid molecules made of lipids and lipid-analogous compounds and use thereof as pharmaceutical or cosmetic preparation |
| 05/12/2011 | WO2010072787A3 A composition comprising a retinoid and method of treating skin conditions |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112199 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 05/12/2011 | US20110112198 Compositions for enhancing hair growth |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112188 Treatment of Inflammatory Conditions |
| 05/12/2011 | US20110112168 Novel sirna structures |
| 05/12/2011 | US20110112166 Therapeutic cyclopentane derivatives |
| 05/12/2011 | US20110112153 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| 05/12/2011 | US20110112150 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| 05/12/2011 | US20110112134 Tricyclic Antagonists of Prostaglandin D2 Receptors |
| 05/12/2011 | US20110112129 Peripheral Phenolic Opioid Antagonist |
| 05/12/2011 | US20110112126 Enzyme inhibiting compounds |
| 05/12/2011 | US20110112121 Pharmaceutical Compositions and Solid Forms |
| 05/12/2011 | US20110112119 Azabicyclooctyl-quinazolone derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/12/2011 | US20110112111 Drug combinations comprising a dgat inhibitor and a ppar-agonist |
| 05/12/2011 | US20110112102 Method of treating cancer using a neuropeptide y 5r (np y5r) antagonist |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112091 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a methof of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 05/12/2011 | US20110112090 Depsipeptides and Their Therapeutic Use |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112082 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 05/12/2011 | US20110112079 Phosphodiesterase inhibitors |
| 05/12/2011 | US20110112078 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use |
| 05/12/2011 | US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 05/12/2011 | US20110112071 Novel heterocyclidene acetamide derivative |
| 05/12/2011 | US20110112069 Purin derivatives for use in the treatment of fab-related diseases |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110112055 Compositions and methods for treating colitis |
| 05/12/2011 | US20110112045 Creamy o/w emulsion composition and production process thereof |
| 05/12/2011 | US20110112041 Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry Disease |
| 05/12/2011 | US20110112019 Method for promoting hair growth or hair regeneration by maintaining or increasing expression of cell-adhesion factor |
| 05/12/2011 | US20110112016 Compositions and methods for modulating the immune system |
| 05/12/2011 | US20110112011 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111059 Compositions Comprising Quinazoline Derivatives, Preparation Methods and Uses Thereof |
| 05/12/2011 | US20110111058 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 05/12/2011 | US20110111035 Inflammation-regulating compositions and methods |
| 05/12/2011 | US20110111031 Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
| 05/12/2011 | US20110111030 Method of Producing Progenitor Cells from Differentiated Cells |
| 05/12/2011 | US20110111010 Method and Composition for Burned Skin |
| 05/12/2011 | US20110111007 Inhibition of retinal cell degeneration or neovascularization by cerium oxide nanoparticles |
| 05/12/2011 | US20110110996 Layer composite, suitable as a wound dressing, comprising a polyurethane foam layer, an absorber layer and a cover layer |
| 05/12/2011 | US20110110988 Topical Compositions Comprising Inorganic Particulates And An Alkoxylated Diphenylacrylate Compound |
| 05/12/2011 | US20110110961 Prolyl hydroxylase inhibitors |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |